Products
SentimenTrader Trading Tools
‍
Backtest Engine
My Trading Toolkit
Correlation Analysis
Seasonality
Market Prediction
Indicators & Data API
‍
Proprietary Indicators & Charts
Market Data API
Strategies & Scanner
‍
50+ Trading Strategies
Smart Stock Scanner
Smart Option Scanner
Research Reports
‍
Research Solutions
Reports Library
Free Resources
Simple Backtest Calculator
Simple Seasonality Calculator
The Kelly Criterion Calculator
Sentiment Geo Map
Public Research Reports
Education
Sentiment Indicators
Technical Indicators
Pricing
Company
About
In the News
Testimonials
Client Success Stories
Contact
Log inLoginSign up
< BACK TO ALL REPORTS

Its time to keep an eye on biotech and metals and mining

Jay Kaeppel
2024-09-16
The biotech sector has enjoyed a good run over the last eleven months. It recently ran into some resistance and is soon entering a period of seasonal weakness. The metals and mining sector is also entering a period of seasonal weakness and has been chopping sideways in 2024. We detail the history and some potential actions herein.

Key points

  • I have been focusing quite a bit on seasonality recently, as many sectors tend to experience weakness during September into October
  • The biotech and metals and mining sectors are nearing a period of potential seasonal weakness with well-established overhead resistance levels overhead
  • One caveat is that it can be dangerous to sell short into strength - but it pays to be prepared in case the market reverses lower

Biotech nears resistance at a critical time

The biotech sector has flown under the radar for much of the last year. The chart below reveals that the iShares Biotechnology ETF (ticker IBB) has advanced +32% since November 2023 and almost +20% since making a higher low in April 2024.

The chart below displays the annual seasonal trend for IBB. Note that an unfavorable period extends from Trading Day of Year (TDY) # 179 through TDY #197. For 2024, that period extends from the close on 2024-09-17 through 2024-10-11.

The chart below displays the hypothetical cumulative $ +(-) achieved by holding a long position in IBB only during the TDY #179 to #197 period since 2002.

The table below summarizes IBB's performance during this period. 

Another biotech ETF to consider is the SPDR S&P Biotech ETF (ticker XBI). It has a shorter but similar history.

For aggressive traders considering playing the short side of the biotech sector, one key thing to note is that options trading volume on ticker XBI is significantly higher than on IBB. Recently, XBI has traded over 50,000 puts in a day (and over 100K calls and puts combined) versus roughly 3,000 puts per day and roughly 5K calls and puts for IBB.

As this seasonally unfavorable period approaches, let's remind ourselves that seasonal trends are most useful when price trends and seasonal trends are at least somewhat in alignment. That is presently not the case for biotech, as IBB and XBI have been trending higher. That said, both do have a "line in the sand" resistance level overhead. Aggressive short-term traders who might consider playing the short side should keep a close eye on the red resistance line drawn on the price chart above. A move above that level would act as a warning sign to bearish traders. 

The Metals and Mining sector is a laggard

With gold and silver soaring of late, one might be surprised to learn that the metals and mining sector is lagging the market badly. In the chart below, we see that the SPDR S&P Metals & Mining ETF (ticker XME) is presently trading below its 200-day moving average and has a meaningful resistance level overhead.

The chart below displays the annual seasonal trend for XME. Note that an unfavorable period extends from Trading Day of Year (TDY) # 179 through TDY #191. For 2024, that period extends from the close on 2024-09-17 through 2024-10-03.

The chart below displays the hypothetical cumulative $ +(-) achieved by holding a long position in ticker XME only during the TDY #179 to #191 period since 2006.

The table below summarizes XME's performance during this period.

A Win Rate of 39% reminds us that the metals and mining sector is not doomed to decline in the weeks ahead. However, the other performance numbers in the table above remind us that upside tends to be limited (median gain of +1.5% and max. gain of +5.4%) while downside risk is concerning (median loss of -6.8% and max. loss of -30.0% - likewise six losses in excess of -6%). The fact that this sector is already experiencing some price weakness as this seasonally unfavorable period begins strongly suggests a potential opportunity.

What the research tells us…

From year to year, any given period that is supposedly "seasonally favorable" or "seasonally unfavorable" can fail to follow the pattern. Seasonality itself should not be thought of as a trading signal. Instead, it tells you "When to look where" for a potential opportunity. As long as the biotech and metals and mining sectors hold below their indicated resistance levels, aggressive traders can consider playing the short side (don't forget to consider options on XBI and XME in order to limit risk on a bearish play versus selling short ETF shares). Longer-term investors in these sectors might either consider hedging their position, raising some cash, or simply "girding their loins" for some potential volatility.

PRODUCTS
SentimenTrader
Trading Tools
Indicators & Data API
‍
Strategies & Scanner
‍
Research Reports
FREE
RESOUrCES
Simple Backtest
Calculator
Simple Seasonality
Calculator
The Kelly Criterion
Calculator
Sentiment Geo Map
‍
Public Research Reports
‍
Education
Sentiment Indicators
‍
Technical Indicators
‍
Pricing
Bundle pricing
‍
FAQ
‍
Announcements
‍
COMPANY
‍
About
‍
In the News
‍
Testimonials
‍
Client Success Stories
CONTACT
‍
General Inquiries
‍
Media Inquiries
‍
Financial Professionals Inquiries
‍
© 2026 Sundial Capital Research Inc. All rights reserved.
Setsail Marketing
TermsPrivacyAffiliate Program
Risk Disclosure: The information and tools provided are for research and analytical purposes only and are not intended as investment advice. Market analysis involves uncertainty, and outcomes may differ from expectations. Users should conduct their own due diligence and consider their individual circumstances before making any financial decisions. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure: Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all which can adversely affect trading results.

Testimonial Disclosure: Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.